Ignite Creation Date:
2024-05-06 @ 7:42 PM
Last Modification Date:
2024-10-26 @ 3:12 PM
Study NCT ID:
NCT06101342
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2023-10-20
Brief Title:
Study of Lenacapavir and EmtricitabineTenofovir Disoproxil Fumarate FTDF for Prevention of HIV in People Who Inject Drugs HPTN 103
Sponsor:
Gilead Sciences
Organization:
Gilead Sciences
Organization Data
Organization:
Gilead Sciences
Class:
INDUSTRY
Study ID:
GS-US-528-6363
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Gilead Sciences
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| HIV Prevention Trials Network | NETWORK |
| National Institute on Drug Abuse NIDA | NIH |
| National Institute of Allergy and Infectious Diseases NIAID | NIH |